Please login to the form below

Not currently logged in
Email:
Password:

Aubagio

This page shows the latest Aubagio news and features for those working in and with pharma, biotech and healthcare.

Sanofi settles Lemtrada dispute with Genzyme investors for $315m

Sanofi settles Lemtrada dispute with Genzyme investors for $315m

At the time, Sanofi was developing its own MS drug called Aubagio (teriflunomide), and the 2015 lawsuit alleged that the company decided to focus its attention on a drug that

Latest news

More from news
Approximately 9 fully matching, plus 39 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics